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This is the first report of benign adult familial myoclonic epilepsy (BAFME) with night blindness. Our cases of BAFME (mother,
son, and daughter) demonstrated night blindness with a reduced b-wave response on electroretinography (ERG) suggesting an
alteration in calcium-mediated neurotransmitter release from photoreceptors in response to light. Several familial epilepsies
have been shown to be due to a channelopathy. On the other hand, the mutation of a calcium-channel gene in Xp11.23 was
recently reported in incomplete X-linked congenital stationary night blindness (CSNB). Although the gene locus of BAFME
was recently assigned to 8q23.3-q24.1, the causative gene has yet to be identified. The present familial case suggests that
BAFME may also be a disease of the calcium channel that is present in the retina and the central nervous system (CNS).
c© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved
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INTRODUCTION
Benign adult familial myoclonic epilepsy (BAFME)
is an autosomal dominant idiopathic epileptic syn-
drome characterized by adult-onset tremulous finger
movement, myoclonus, epileptic seizures, and a
nonprogressive course1. Although the gene locus was
recently assigned to 8q23.3-q24.12, 3, the causative
gene has yet be identified. On the other hand, congen-
ital stationary night blindness (CSNB) is a clinically
and genetically heterogeneous non-progressive eye
disorder with life-long impairment of night vision
and variably reduced day vision. The mutation of
a calcium-channel gene in Xp11.23 was recently
identified in incomplete X-linked CSNB4, 5. We
present here three family cases (mother, son, and
daughter) of BAFME with night blindness.
CASE REPORTS
Patient 1
A 34-year-old man noticed night blindness at the
age of 13, bilateral tremulous finger movement at 16
with twitching of the upper and lower extremities
(myoclonus) at times of fatigue. His mother had
similar symptoms (Fig. 1, patient 2). On admission,
there were no particular findings from a general
medical examination. Neurological findings included
fine tremulous movements in the fingers and my-
oclonus in the upper and lower extremities at rest
without clouding of consciousness or dementia. Deep
tendon reflexes were normal, and no pathological
reflexes, ataxia, or sensory disorders were noted. The
peripheral blood profile, general biochemical findings,
urinary and faecal examinations were all normal.
Brain magnetic resonance imaging (MRI) revealed
no abnormal finding. An electroencephalogram (EEG)
showed polyspikes and wave complexes in the
occipital lobe. Somatosensory evoked potentials (SEP)
recorded by stimulation of the median nerve at the
wrist showed marked increase in P25 and N33 to
20 µV a Long-loop reflex (C reflex) could be induced
with a latency of 40 ms at rest from the ipsilateral
thenar muscle by stimulation at the same site. Positive
spikes preceding myoclonus by 20 ms were observed
in the centro-parietal region on the contralateral side
of myoclonus by the jerk-locked averaging method
using myoclonus of the upper extremity as a trigger.
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Dark adaptation was decreased (Fig. 2) and an
electroretinogram (ERG) showed a marked decrease
in the amplitude of b-waves (Fig. 3). Treatment with
clonazepam and valproic acid was very effective in
relieving his tremor and myoclonus.
Fig. 1: Pedigree of family suggests autosomal dominant
inheritance with a high rate of penetrance. All affected
persons had a history of myoclonic movement and epilepsy
with adult onset.
Fig. 2: Dark adaptation in patient 1 decreased. Vertical and
horizontal axes indicate threshold (log) and dark adaptation
time, respectively.
Fig. 3: ERG in patient 1 showed a marked decrease in the
amplitude of b-waves.
Patient 2
A 61-year-old woman, the mother of patient 1,
presented with night blindness since childhood,
myoclonus in the upper and lower extremities at times
of fatigue from the age of 30 and generalized seizures
from the age of 33. Neurological findings revealed fine
tremulous movements in the fingers. An EEG showed
generalized spikes or polyspike and wave complexes.
She revealed the enlarged cortical components of
SEP, enhanced long-loop reflex, and positive spikes
preceding myoclonus, ascertained with the jerk-locked
averaging method. Dark adaptation was decreased and
ERG revealed small b-waves. With administration of a
β-blocker and valproic acid, she recovered sufficiently
to have no difficulty in working or in her daily life.
Patient 3
A 31-year-old woman, the sister of patient 1, presented
with myoclonus in the upper and lower extremities at
times of fatigue from the age 27. Neurological findings
revealed fine tremulous movements in the fingers.
EEG showed generalized spikes or polyspike and
wave complexes. She revealed the enlarged cortical
components of SEP, enhanced long-loop reflex, and
positive spikes preceding myoclonus, ascertained with
the jerk-locked averaging method. Although she has
no subjective night blindness, dark adaptation was
decreased. With administration of clonazepam, she
had no difficulty in working or in her daily life.
Although other family members have no subjective
night blindness, they have not been examined for
dark adaptation and by ERG. All three patients were
photosensitive.
DISCUSSION
The clinical features of BAFME consist of (i) auto-
somal dominant inheritance, tremulous finger move-
ment, and/or myoclonus of the extremities after ado-
lescence; (ii) infrequent epileptic seizures; (iii) abnor-
mal polyspikes and waves on EEG and marked photo-
sensitivity; (iv) enlarged cortical components of SEP;
(v) enhanced long-loop reflex; (vi) positive spikes
preceding myoclonus, ascertained with the jerk-locked
averaging method; and (vii) benign nonprogressive
course without cerebellar ataxia and dementia1, 2, 6.
However, BAFME with night blindness has never been
reported.
The gene locus of BAFME was recently assigned to
8q23.3-q24.12, 3. Significant progress has been made
in the mapping and isolation of genes for the epilepsy
syndrome. For example, genetic loci for two types
of benign familial neonatal convulsion (BFNC) have
been mapped on 20q (BFNC1) and 8q24 (BFNC2)
with mutations in a voltage-gated potassium-channel
gene (KCNQ2)7 and (KCNQ3)8, respectively.
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On the other hand, the mutation of a retina-specific
calcium channel α1-subunit gene (CACNA1F) in
Xp11.23 was identified in the incomplete form of X-
linked CSNB4, 5. L-type calcium channels consist of
four subunits (α1, α2δ, β and γ ), with the calcium-
conducting pore located in the α1-subunit. Three
autosomal L-type channel α1 genes have been cloned
thus far: α1s from skeletal muscle, α1c from cardiac
muscle and brain, and α1d from neural and endocrine
tissues4. Thus, a common calcium channel gene may
exist in brain and retina.
Our patients showed night blindness with a reduced
b-wave response on ERG. Light-induced hyperpolar-
ization of photoreceptor cells diminishes the release
of neurotransmitters at their synaptic terminals, which
in turn leads to the depolarization of ON-bipolar and
horizontal cells. This depolarization of bipolar cells
causes the subsequent depolarization of Mu¨ller cells,
which appear largely to be the origin of the retinal
positive b-wave. ERG results in our patients were
more supportive of decreased transmitter release with
abnormal inner nuclear layer activity as reflected in
the rod and cone b-wave. The influx of extracellular
calcium into photoreceptor cells mediates the release
of the neurotransmitter. Mutations in the α1-subunit
of the L-type calcium channel impair the influx of
Ca2+ that is required for tonic release of glutamate
from photoreceptor presynaptic terminals in darkness.
Therefore, the present cases suggest a possibility that
a common calcium channel in the retina (especially
the Mu¨ller cells) and the CNS may be involved in
BAFME.
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